tomeko

Gonadotropin-independent familial sexual precocity

Just diagnosed with Gonadotropin-independent familial sexual precocity?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Gonadotropin-independent familial sexual precocity, look for clinical trials, and connect with others living with it — all in one place.

Open the full Gonadotropin-independent familial sexual precocity hub →

Overview

Gonadotropin-independent familial sexual precocity is a rare condition. Also known as FMPP, Familial gonadotropin-independent male-limited sexual precocity, Male-limited precocious puberty, Testotoxicosis. Tomeko brings together the specialists, research, clinical trials, treatments and community for Gonadotropin-independent familial sexual precocity so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:3000 · OMIM 176410 · ICD-10 E30.1 · GARD 0004475

Find care for Gonadotropin-independent familial sexual precocity

Authoritative references for Gonadotropin-independent familial sexual precocity

Common questions

I was just diagnosed with Gonadotropin-independent familial sexual precocity — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Gonadotropin-independent familial sexual precocity, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Gonadotropin-independent familial sexual precocity?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Gonadotropin-independent familial sexual precocity, filtered to your area.

Are there clinical trials for Gonadotropin-independent familial sexual precocity?

Tomeko shows live, recruiting studies for Gonadotropin-independent familial sexual precocity from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com